Wihl J A, Pilström L, Maasch H J
Int Arch Allergy Appl Immunol. 1985;76(2):162-7. doi: 10.1159/000233684.
The allergenic activities of allergen (GEN) and allergoid (GOID) preparations from partially purified timothy pollen extract were investigated in quantitative skin prick tests and nasal provocation tests. In skin prick test GOID yielded significantly less activity than GEN. Approximately 90 times more protein of GOID than of GEN was necessary to elicit wheals of the same mean size as 1 mg/ml histamine control solution (1 HEP). In nasal provocation the patients seemed to react differently with respect to their nasal sensitivity to GOID. One group of patients showed equal sensitivity to GOID and GEN, whereas the second group showed higher thresholds to GOID. These differences in nasal sensitivity to GOID could be of practical value to predict the optimal dosage schedule for the treatment of patients with GOID.
对部分纯化的梯牧草花粉提取物中的过敏原(GEN)和类过敏原(GOID)制剂的变应原活性进行了定量皮肤点刺试验和鼻激发试验研究。在皮肤点刺试验中,GOID产生的活性明显低于GEN。要诱发与1mg/ml组胺对照溶液(1HEP)相同平均大小的风团,所需的GOID蛋白量比GEN大约多90倍。在鼻激发试验中,患者对GOID的鼻敏感性反应似乎有所不同。一组患者对GOID和GEN的敏感性相同,而另一组对GOID的阈值较高。这些对GOID鼻敏感性的差异对于预测GOID患者治疗的最佳剂量方案可能具有实际价值。